Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Point-of-care
100%
Allogeneic
100%
Pulmonary Complications
100%
Red Blood Cells
100%
Cell Washing
100%
Transfusion
100%
Leukocytes
85%
Red Blood Cell Transfusion
57%
Autotransfusion System
42%
Transfusion-related Acute Lung Injury (TRALI)
42%
Transfusion-associated Circulatory Overload
28%
Cardiac Surgery Patients
28%
Clinical Outcomes
28%
Biological Response Modifiers
28%
Adult Cardiac Surgery
28%
Respiratory Complications
28%
Effective Strategies
28%
Noninfectious Complications
14%
Storage Solution
14%
Funding Opportunity Announcement
14%
Immunomodulatory
14%
Safety Efficacy
14%
Blood Products
14%
Clinical Impact
14%
Risk Prediction Model
14%
Transfusion Strategy
14%
Randomized Clinical Trial
14%
Blood Transfusion
14%
FDA-approved Drugs
14%
Day of Surgery
14%
Postoperative Pulmonary Complications
14%
Red Blood Cell Storage
14%
Preparation Strategy
14%
High-risk Cardiac Surgery
14%
Specific Aims
14%
Safety Impact
14%
Blood Components
14%
Transfusion-related Adverse Events
14%
Medicine and Dentistry
Erythrocyte
100%
Leukocyte
66%
Erythrocyte Transfusion
44%
Heart Surgery
33%
Blood Autotransfusion
33%
Transfusion Related Acute Lung Injury
33%
Biological Response Modifier
22%
Erythrocyte Preservation
11%
Blood Transfusion
11%
Infectious Complication
11%
Blood Product
11%
Blood Component
11%
Randomized Clinical Trials
11%
Prediction Model
11%
Day of Surgery
11%
Adverse Event
7%
Nursing and Health Professions
Erythrocyte
100%
Erythrocyte Transfusion
44%
Heart Surgery
33%
Autotransfusion Unit
33%
Transfusion Related Acute Lung Injury
33%
Accident Prevention
22%
Biological Response Modifier
22%
Efficacy
22%
Clinical Outcome
22%
Infectious Complication
11%
Erythrocyte Preservation
11%
Blood Transfusion
11%
Food and Drug Administration
11%
Adverse Event
11%
Clinical Trial
11%